Article Text

Download PDFPDF
Gastroprotective effects of oral nucleotide administration
  1. A Belo,
  2. T Marchbank,
  3. A Fitzgerald,
  4. S Ghosh,
  5. R J Playford
  1. Department of Gastroenterology, Imperial College, Hammersmith Hospital Campus, London, UK
  1. Correspondence to:
    Dr T Marchbank
    Department of Gastroenterology, Imperial College Faculty of Medicine, Hammersmith Hospital, Ducane Rd, London W12 0NN, UK; t.marchbank{at}


Background and aims: Nucleotides form the building blocks of DNA and are marketed as dietary supplements, alone or in combination with other ingredients, to promote general health. However, there has been only limited scientific study regarding the true biological activity of orally administered nucleotides. We therefore tested their efficacy in a variety of models of epithelial injury and repair.

Methods: Effects on proliferation ([3H] thymidine incorporation) and restitution (cell migration of wounded monolayers) were analysed using HT29 and IEC6 cells. The ability of a nucleotide mixture to influence gastric injury when administered orally and subcutaneously was analysed using a rat indomethacin (20 mg/kg) restraint model.

Results: In both cell lines, cell migration was increased by approximately twofold when added at 1 mg/ml (p<0.01); synergistic responses were seen when a mixture of nucleotides was used. Cell proliferation was stimulated by adenosine monophosphate (AMP) in HT29, but not in IEC6, cells. Gastric injury was reduced by approximately 60% when gavaged at 4–16 mg/ml (p<0.05), concentrations similar to those likely to be found in consumers taking nucleotide supplements. Systemic administration of nucleotides was unhelpful.

Conclusions: Nucleotides possess biological activity when analysed in a variety of models of injury and repair and could provide a novel inexpensive approach for the prevention and treatment of the injurious effects of non steroidal anti-inflammatory drugs and other ulcerative conditions of the bowel. Further studies on their potential benefits (and risks) appear justified.

  • AMP, adenosine monophosphate
  • CMP, cytidine monophosphate
  • GMP, guanosine monophosphate
  • IMP, inosine monophosphate
  • DMEM, Dulbecco’s modified Eagle’s medium
  • EGF, epidermal growth factor
  • NSAID, non-steroidal anti-inflammatory drugs
  • NT, nucleotides
  • repair
  • gut growth
  • cell migration
  • injury
  • nutriceutical

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Published online first 9 August 2005

  • Conflict of interest: None declared.